Opaleye Management Inc., a significant shareholder of Harrow, Inc. (NASDAQ: HROW), has recently sold a portion of its holdings in the company. According to a filing with the Securities and Exchange ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SANUWAVE Health Inc., headquartered in the USA, specializes in the development and commercialization of patented ultrasound and shock wave technology for regenerative medicine. The company's flagship ...

Harrow is a leading ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of eye-care products for the North American market. Its portfolio of branded products ...

Opaleye Management Inc. has not disclosed any specific intentions or future plans regarding its investment in Harrow Inc. following this latest transaction. The firm, based in Boston, MA, is known for ...

Opaleye Management Inc. (Trades, Portfolio), a prominent investment firm, recently adjusted its holdings in Protara Therapeutics Inc. (NASDAQ:TARA) by reducing its stake. On September 12, 2024, the ...

Opaleye Management Inc. disposed of 198,572 shares indirectly across two days, with a transaction value of roughly $7.8 million based on weighted average prices of $39.15 on March 3 and $39.67 on ...